HighTower Advisors LLC Has $1.79 Million Stake in Humana Inc. (NYSE:HUM)

HighTower Advisors LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 21.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,047 shares of the insurance provider’s stock after selling 1,945 shares during the quarter. HighTower Advisors LLC’s holdings in Humana were worth $1,788,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. FPC Investment Advisory Inc. purchased a new stake in Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC purchased a new stake in Humana in the 4th quarter valued at $30,000. OFI Invest Asset Management purchased a new stake in Humana in the 4th quarter valued at $33,000. Atwood & Palmer Inc. raised its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after buying an additional 60 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Humana in the 4th quarter valued at $49,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. lowered their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Truist Financial upped their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Morgan Stanley reduced their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $285.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is currently owned by company insiders.

Humana Stock Down 0.2 %

Shares of NYSE HUM opened at $266.33 on Monday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $32.14 billion, a P/E ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The business has a 50-day simple moving average of $271.33 and a two-hundred day simple moving average of $276.25.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. Humana’s payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.